Brain Tumours: Classification and Genes

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2004 May 18

PMID 15146033

Citations 39

Authors

V P Collins

Affiliations

Soon will be listed here.

Citing Articles

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities.

Zhang J, Zhang J, Yang C J Transl Med. 2025; 23(1):52.

PMID: 39806481 PMC: 11727735. DOI: 10.1186/s12967-024-06063-0.

PMS2 amplification contributes brain metastasis from lung cancer.

Chen J, Hu C, Yang H, Wang L, Chu X, Yu X Biol Proced Online. 2024; 26(1):12.

PMID: 38714954 PMC: 11075212. DOI: 10.1186/s12575-024-00238-1.

Nanoparticle-based Gene Therapy for Neurodegenerative Disorders.

Ereej N, Hameed H, Khan M, Faheem S, Hameed A Mini Rev Med Chem. 2024; 24(19):1723-1745.

PMID: 38676491 DOI: 10.2174/0113895575301011240407082559.

Current understanding of gliomagenesis: from model to mechanism.

Luo J, Junaid M, Hamid N, Duan J, Yang X, Pei D Int J Med Sci. 2022; 19(14):2071-2079.

PMID: 36483593 PMC: 9724244. DOI: 10.7150/ijms.77287.

Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.

Verreault M, Vilchis I, Rosenberg S, Lemaire N, Schmitt C, Guehennec J Clin Transl Med. 2022; 12(7):e939.

PMID: 35808822 PMC: 9270581. DOI: 10.1002/ctm2.939.

References

Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff J . Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 2000; 14(13):1617-30. PMC: 316733. View

Gutmann D, Donahoe J, Brown T, James C, Perry A . Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol. 2000; 26(4):361-7. DOI: 10.1046/j.1365-2990.2000.00258.x. View

Bayani J, Zielenska M, Marrano P, Kwan Ng Y, Taylor M, Jay V . Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg. 2000; 93(3):437-48. DOI: 10.3171/jns.2000.93.3.0437. View

Herms J, Neidt I, Luscher B, Sommer A, Schurmann P, Schroder T . C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer. 2000; 89(5):395-402. View

Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P, Ohgaki H . Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res. 2001; 60(24):6868-74. View

Costello J, Plass C, Cavenee W . Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathol. 2001; 17(2):49-56. DOI: 10.1007/BF02482735. View

Cai D, James C, Scheithauer B, Couch F, Perry A . PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol. 2001; 115(2):213-8. DOI: 10.1309/FVNU-7UBY-DXE3-77MT. View

Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Hoppner W . Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer. 2001; 91(6):803-8. DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1134>3.0.co;2-p. View

Gilbertson R, Hernan R, Pietsch T, Pinto L, Scotting P, Allibone R . Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma. Genes Chromosomes Cancer. 2001; 31(3):288-94. DOI: 10.1002/gcc.1146. View

10.

Cai D, Banerjee R, Scheithauer B, Lohse C, Kleinschmidt-DeMasters B, Perry A . Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol. 2001; 60(6):628-36. DOI: 10.1093/jnen/60.6.628. View

11.

Sonoda Y, Ozawa T, Hirose Y, Aldape K, McMahon M, Berger M . Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res. 2001; 61(13):4956-60. View

12.

Koch A, Waha A, Tonn J, Sorensen N, Berthold F, Wolter M . Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer. 2001; 93(3):445-9. DOI: 10.1002/ijc.1342. View

13.

Grotzer M, Hogarty M, Janss A, Liu X, Zhao H, Eggert A . MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res. 2001; 7(8):2425-33. View

14.

Alonso M, Bello M, Lomas J, Gonzalez-Gomez P, Arjona D, De Campos J . Absence of mutation of the p73 gene in astrocytic neoplasms. Int J Oncol. 2001; 19(3):609-12. DOI: 10.3892/ijo.19.3.609. View

15.

Kraus J, De Millas W, Sorensen N, Herbold C, Schichor C, Tonn J . Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathol. 2001; 102(1):69-74. DOI: 10.1007/s004010000353. View

16.

Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, Ostertag H . Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol. 2001; 60(9):917-20. DOI: 10.1093/jnen/60.9.917. View

17.

Dahmen R, Koch A, Denkhaus D, Tonn J, Sorensen N, Berthold F . Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res. 2001; 61(19):7039-43. View

18.

MacDonald T, Brown K, LaFleur B, Peterson K, Lawlor C, Chen Y . Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet. 2001; 29(2):143-52. DOI: 10.1038/ng731. View

19.

Shaw R, Paez J, Curto M, Yaktine A, Pruitt W, Saotome I . The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell. 2001; 1(1):63-72. DOI: 10.1016/s1534-5807(01)00009-0. View

20.

Buschges R, Ichimura K, Weber R, Reifenberger G, Collins V . Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas. Brain Pathol. 2002; 12(2):145-53. PMC: 8095877. DOI: 10.1111/j.1750-3639.2002.tb00429.x. View